GRAIL Poaches New CEO From Roche, Genentech Post author:Sam Post published:December 13, 2017 Post category:BioPharma Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace You Might Also Like Johnson & Johnson Yanks Plans for First R&D Facility in the UK November 27, 2017 Elite Pharma Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information June 14, 2017 Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Ce… October 30, 2017
Elite Pharma Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information June 14, 2017
Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Ce… October 30, 2017